glp-1 nasal spray AMS Gastric Settle Equate Fluticasone Propionate Nasal Allergy

Not what the optimization culture says they are

While pregnancy should be avoided on any weight loss medication, the teratogenicity risk with Qsymia (specifically topiramate causing cleft palate) is uniquely severe

[27] Gastroparesis has been associated with connective tissue disorders such as Marfan syndrome, LoeysDietz syndrome and EhlersDanlos syndrome

Similarly, physiological increases in GLP-2 with refeeding increase villus length and crypt-cell proliferation in an epithelial-IGF-dependent manner 52

With semaglutide producing roughly 15-17% weight loss and tirzepatide achieving 20-22% , both medications already generate hair loss reports